Antibodies to β2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions

Archives of Gynecology and Obstetrics

Volumn 274, Issue 5, 2006, Pages 261-265

  Zammiti, W ^a   Mtiraoui, N ^a   Hidar, S ^b   Fekih, M ^b   Almawi, W Y ^c   Mahjoub, T ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOCORTIN 5; LIPOCORTIN 5 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; RECURRENT ABORTION; REGRESSION ANALYSIS; RISK FACTOR; SPONTANEOUS ABORTION; TUNISIA; BLOOD; IMMUNOLOGY; PREGNANCY;

ABORTION, HABITUAL; ADULT; ANNEXIN A5; ANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREVALENCE; RISK FACTORS;

EID: 33746453267     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0158-7     Document Type: Article

References (32)

1. Ailus K, Tulppala M, Palosuo T, Ylikorkala O, Vaarala O (1996) Antibodies to beta 2-glycoprotein I and prothrombin in habitual abortion. Fertil Steril 66:937-941
2. Arai T, Matsubayashi H, Sugi T, Kondo A, Shida M, Suzuki T, Izumi SI, McIntyre JA, Makino T (2003) Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. Am J Reprod Immunol 50:202-208
3. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H (2001) Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 113:911-914
4. Chaouat G, Menu E, Delage G, Moreau JF, Khrishnan L, Hui L, Meliani AA, Martal J, Raghupathy R, Lelaidier C et al (1995) Immuno-endocrine interactions in early pregnancy. Hum Reprod 10(Suppl 2):55-59
5. Di Simone N, Castellani R, Caliandro D, Caruso A (2001) Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 65:1766-1770
6. Esmon NL, Smirnov MD, Esmon CT (1997) Lupus anticoagulants and thrombosis: the role of phospholipids. Haematologica 82:474-477
7. Falcon CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO (1997) Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 89:975-980
8. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO (1997) Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 78:1008-1014
9. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544-1547
10. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daures JP, Mares P (1999) Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the nimes obstetricians and haematologists study5 (NOHA5). Thromb Haemost 81:891-899
11. Gris JC, Quere I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM, Ripart-Neveu S, Hoffet M, Tailland ML, Rousseau O, Monpeyrouxm F, Dauzat M, Sampol J, Daures JP, Berlan J, Mares P (2000) Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The nimes obstetricians and haematologists study-NOHA. Thromb Haemost 84:228-236
12. Gris JC, Perneger TV, Quere I, Mercier E, Fabbro-Peray P, Lavigne-Lissalde G, Hoffet M, Dechaud H, Boyer JC, Ripart-Neveu S, Tailland ML, Daures JP, Mares P, Dauzat M (2003) Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 102:3504-3513
13. Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR (2005) The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening. Am J Obstet Gynecol 193:395-403
14. Lee RM, Emlen W, Scott JR, Branch DW, Silver RM (1999) Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and anti-phospholipid syndrome. Am J Obstet Gynecol 181:642-648
15. Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752-763
16. Lynch A, Byers T, Emlen W, Rynes D, Shetterly SM, Hamman RF (1999) Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy. Obstet Gynecol 93:193-198
17. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, Almawi WY (2005) Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Am J Hematol 80:12-19
18. Marai I, Tincani A, Balestrieri G, Shoenfeld Y (2005) Anti-cardiolipin and anti-beta-2-glycoprotein I antibodies. Autoimmunity 38:33-38
19. Martinuzzo ME, Forastiero RR, Carreras LO (1995) Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 89:397-402
20. Matsubayashi H, Arai T, Izumi S, Sugi T, McIntyre JA, Makino T (2001) Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 76:694-699
21. Mercanoglu F, Erdogan D, Oflaz H, Kucukkaya R, Selcukbiricik F, Gul A, Inanc M (2004) Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome. Int J Clin Pract 58:1003-1007
22. Miyakis S, Giannakopoulos B, Krilis SA (2004) Beta 2 glycoprotein I-function in health and disease. Thromb Res 114:335-346
23. Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris J-C, Almawi WY, Mahjoub T (2005) Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol 119:164-170
24. Norwitz ER, Schust DJ, Fisher SJ (2001) Implantation and the survival of early pregnancy. N Engl J Med 345:1400-1408
25. Quenby S, Farquharson RG, Dawood F, Hughes AM, Topping J (2005) Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod 20:1729-1732
26. Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J, Lockwood CJ (1994) Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 171:1566-1572
27. Rand J, Eerden PV, Wu XX, Chazotte C (2005) Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome. Thromb Res 115(Suppl 1):77-81
28. Romisch J, Seiffge D, Reiner G, Paques EP, Heimburger N (1991) In-vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb Res 61:93-104
29. Siaka C, Lambert M, Caron C, Amiral J, Hachulla E, Hatron PY, Goudemand J (1999) Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss. Rev Med Interne 20:762-765
30. Van Ryn-McKenna J, Merk H, Muller TH, Buchanan MR, Eisert WG (1993) The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost 69:227-230
31. Wang X, Campos B, Kaetzel MA, Dedman JR (1999) Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 180:1008-1016
32. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC (1988) Incidence of early loss of pregnancy. N Engl J Med 319:189-194